PepDose
Animal and lab dataLongevity & MitochondrialReviewed Nov 13, 2026

MOTS-c

A 16-amino-acid peptide encoded in mitochondrial DNA. The research is in mice and cells; no human trial of MOTS-c as a treatment is cited here. It is not approved.

amino acids, encoded in mitochondrial DNA
16

amino acids, encoded in mitochondrial DNA[1]

where obesity and insulin resistance were prevented
Mice

where obesity and insulin resistance were prevented[1]

late-life dosing schedule that raised physical capacity in old mice
3x/week

late-life dosing schedule that raised physical capacity in old mice[2]

no human exposure data identified by the FDA
Not approved

no human exposure data identified by the FDA[3]

4 sources, every claim linked. PepDose sells no peptides and takes no vendor money.

01 · What it is

What is MOTS-c?

MOTS-c is a 16-amino-acid peptide encoded by a short open reading frame inside the mitochondrial 12S rRNA gene. Most peptides are encoded in the cell nucleus, which is why MOTS-c is called a mitochondrial-derived peptide.

Your body makes it naturally. Products sold as MOTS-c are synthetic copies sold as research chemicals, and they are not approved as medicines.

Illustration of cellular energy

Illustration.

02 · How it works

How does MOTS-c work?

In cell and mouse work, its main target was skeletal muscle. It inhibited the folate cycle and the linked making of purines, which led to activation of AMPK, an enzyme that senses cellular energy. These mechanisms come from cells and mice.

03 · Research

What does the research on MOTS-c show?

Studies are in mice and cells. In mice, MOTS-c treatment prevented age-dependent and high-fat-diet-induced insulin resistance and diet-induced obesity. It also improved physical performance in young, middle-aged and old mice. In people, studies cited here measured natural MOTS-c levels, not a treatment.

  • In mice, MOTS-c treatment prevented age-dependent and high-fat-diet-induced insulin resistance, as well as diet-induced obesity. Skeletal muscle appeared to be its primary target organ.[1]
  • A later mouse study found MOTS-c improved physical performance in young (2 months), middle-aged (12 months) and old (22 months) mice, and that intermittent treatment (3 times a week) started late in life (23.5 months) increased physical capacity and healthspan. Two authors disclose being consultants and shareholders of CohBar, Inc.[2]
  • In people, the same study reported that exercise induces the body's own MOTS-c in skeletal muscle and in the blood. This measured natural levels, not a MOTS-c treatment.[2]
  • A 2026 study measured blood levels of MOTS-c and other mitochondrial-derived peptides in adults with cerebral palsy and in typically developing adults and adolescents. Levels at rest were comparable between groups, and the peptides showed no or only modest changes one hour after 45 minutes of running. It did not test MOTS-c as a treatment.[4]

04 · Side effects

What are the side effects of MOTS-c?

Safety in people is unknown. The FDA says it has not identified any human exposure data on drug products containing MOTS-c by any route. It also flags a risk of immune reactions and notes impurity and characterization problems. Because products are unregulated, purity and dose are unknown.

  • The FDA says it has not identified any human exposure data on drug products containing MOTS-c administered by any route, so side effects in people are not known.[3]
  • The FDA also says compounded MOTS-c may pose a significant risk of immune reactions for certain routes, and notes peptide-related impurities and challenges in characterizing the substance.[3]
  • Because products are unregulated, purity and the actual amount in a vial are unknown.[3]

Commonly listed reasons to avoid it

  • Pregnancy and breastfeeding

Not approved

05 · Legal and regulatory status

Is MOTS-c FDA-approved?

No. MOTS-c is not an FDA-approved medicine. The FDA lists it in its table of bulk substances nominated for compounding and then withdrawn, and says it has not identified human exposure data. Vials sold online are unregulated research products.

  • Not FDA-approved. The FDA's compounding page (as of 22 April 2026) lists MOTS-c in its table of bulk substances nominated but withdrawn, and states it has not identified any human exposure data on drug products containing it.[3]
Animal and lab dataMostly animal or lab studies. Little or no human clinical evidence.

06 · Mixing and units

How do you mix MOTS-c and read the units?

Units on a U-100 syringe = dose (mg) ÷ concentration (mg/mL) × 100. For example, a 5 mg vial mixed with 2 mL of bacteriostatic water is 2.5 mg/mL, so 10 units hold 0.25 mg. Pick your vial and water below; the maths is the same for any brand of MOTS-c.

Vial of powder, vial of water, 1 mL syringe and alcohol swabs
1234
  1. 1 Peptide vial
  2. 2 Bacteriostatic water
  3. 3 U-100 syringe
  4. 4 Alcohol swabs

Vial size

Water added

MOTS-c in the vial
5 mg
Water added
2 mL
Strength
2.5 mg/mL
1 unit holds
25 mcg
Open in the calculatorU-100 insulin syringe: 100 units = 1 mL.
  1. Step 1

    Clean

    Wipe the vial stopper with an alcohol swab and let it dry.

  2. Step 2

    Add water

    Let the bacteriostatic water run slowly down the inside wall of the vial.

  3. Step 3

    Swirl

    Swirl or roll gently until clear. Don't shake.

  4. Step 4

    Label and chill

    Write the date and strength (mg/mL) on the vial and keep it in the fridge.

Members

The full MOTS-c protocol

  • Week-by-week schedule and titration
  • What to track and when
  • Stacking notes and timing
  • Dose tracker with injection-site rotation
  • Every study explained in detail
  • Step-by-step start guide
See the library

07 · Questions

Common questions about MOTS-c

What is MOTS-c?

A 16-amino-acid peptide encoded in mitochondrial DNA, which makes it a mitochondrial-derived peptide. The body makes it naturally. Research so far is mostly in mice and cells.

What does MOTS-c do?

In mice it prevented diet-induced obesity and insulin resistance and improved physical performance. Its main target appeared to be skeletal muscle, where it activated AMPK, an enzyme that senses cellular energy. These results have not been shown in human trials.

Has MOTS-c been tested in humans?

Studies cited here measured the body's own MOTS-c, for example around exercise, but did not test MOTS-c as a treatment. The FDA says it has not identified human exposure data on drug products containing MOTS-c.

Is MOTS-c FDA-approved?

No. It is not an approved medicine. The FDA lists it among bulk substances nominated for compounding and then withdrawn.

What are the side effects of MOTS-c?

They are not known in people. The FDA has identified no human exposure data and flags a risk of immune reactions, plus impurity concerns, for compounded forms.

How much BAC water for a 10 mg MOTS-c vial?

With 2 mL the vial is 5 mg/mL, so 10 units on a U-100 syringe holds 0.5 mg and 20 units holds 1 mg. With 1 mL it is twice as strong per unit.

Sources

  1. 1.The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance
    Lee C et al. Cell Metab 2015;21:443-454 · Animal study
  2. 2.MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis
    Reynolds JC et al. Nat Commun 2021;12:470 · Animal study
  3. 3.FDA compounding safety-risk list
    FDA. Bulk drug substances for compounding that may present significant safety risks (as of Apr 22, 2026) · FDA
  4. 4.Circulating mitochondrial-derived microproteins at rest and in response to an acute bout of endurance exercise in individuals with cerebral palsy
    Horwath O et al. Exp Physiol 2026;111:3772-3783 · Human, small study

How we choose and check sources: editorial policy. Unit maths: methodology.

Related peptides